Riccardo Vizza

Dr. Riccardo Vizza

Division of Obstetrics and Gynecology, Università di Verona, Italy, Verona, Veneto, Italy
orcid
Resident doctor

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2022 in Italian Journal of Gynaecology and Obstetrics
Verified
Journal Article
Closed access
ODO. D’oria
O. D’oria
Tullio Golia D'AugèTullio Golia D'Augè
Tullio Golia D'Augè
EBE. Baiocco
E. Baiocco
CVC. Vincenzoni
C. Vincenzoni
EME. Mancini
E. Mancini
AGA. Giannini
A. Giannini

18 April 2023 in Sexual Medicine Reviews
Verified
Journal Article
Open access
PDF file
Riccardo VizzaRiccardo Vizza
Riccardo Vizza
ECElisabetta Maria Capomolla
Elisabetta Maria Capomolla
LTLivia Tosetto
Livia Tosetto
GCGiacomo Corrado
Giacomo Corrado
VBValentina Bruno
Valentina Bruno
PVPatrizia Vici
Patrizia Vici
In breast cancer patients, endocrine therapy may exert a negative impact on sexual functioning in both genders, with potentially relevant consequences concerning quality of life and treatment adherence. The availability of effective interventions to maintain and/or restore sexual health in breast cancer patients is a key issue to a research agenda. To summarize and critically discuss the most updated and qualitatively relevant literature on the therapeutic approach to sexual impairment in breast cancer patients, with a focus on patients treated with endocrine therapy. We searched PubMed from its inception to February 2022 for observational and intervention trials including participants with sexual dysfunctions. We were particularly interested in studies of breast cancer patients with sexual dysfunctions while undergoing endocrine therapy. We developed a search strategy with the aim of maximizing the number of articles considered for screening and potential inclusion. Forty-five studies were selected: 3 observational and 42 intervention studies. Thirty-five studies were exclusively focused on female breast cancer populations. We could not identify studies exclusively focused on or also including male breast cancer patients. Overall, in female patients, the available armamentarium encompasses vaginal lubricants, moisturizers, estrogens, dehydroepiandrosterone, CO2 laser, ospemifene, and counseling. None of these interventions has been demonstrated to completely solve sexual dysfunctions when singularly considered. More favorable outcomes have come from the combination of different therapies. In female breast cancer, future research is oriented toward the gain of evidence on combined therapies and long-term data on safety issues on the most promising interventions. The lack of evidence on sexual disturbances in male breast cancer patients remains a major concern.

18 June 2025 in European Journal of Surgical Oncology
Verified
Journal Article
Open access
EVEnrico Vizza
Enrico Vizza
Andrea GianniniAndrea Giannini
Andrea Giannini
VBValentina Bruno
Valentina Bruno
EBErmelinda Baiocco
Ermelinda Baiocco
EMEmanuela Mancini
Emanuela Mancini
GBGiorgio Bogani
Giorgio Bogani
Robotic-assisted surgery has emerged as an effective method for managing endometrial cancer. Recently, the new Da Vinci Single-Port (SP) was developed with the aim of minimizing surgery-related morbidity, using a single-port approach. The present research evaluated outcomes of apparent early-stage endometrial cancer patients undergoing single- and multi-port robotic-assisted surgery. This is a retrospective study. Data of consecutive patients affected by early-stage endometrial cancer who had robotic-assisted staging (including hysterectomy, bilateral salpingo-oophorectomy and nodal staging) with Da Vinci SP were matched 1:1 with a cohort of patients undergoing robotic-assisted surgery with the multi-port Da Vinci Xi. The matching was conducted by a propensity-score comparison. Fifty patient pairs (50 undergoing single-port surgical staging vs. 50 undergoing multiple-port surgical staging) were included. Demographic and baseline characteristics were balanced between groups. Median (skin to skin) operative time (minutes) was similar between groups (120 (range, 70-229) in the single-port vs. 115 (range, 60-205) in the multi-port group; p = 0.367). Estimated blood loss was comparable between groups (p = 0.317). No intra-operative complications or intra-operative blood transfusions were recorded. The median length of hospital stay was similar between groups (p = 0.269). Overall, 10 (10 %) patients developed 90-day surgery-related complications: six (12 %) and four (8 %) in the single- and multi-port group, respectively (p = 0.740). One (2 %) and two (4 %) patients experienced severe (grade 3 or more) 90-day complications after single- and multi-port robotic-assisted staging (p = 1.00). Introducing Da Vinci SP appears to be safe and feasible. The single-port approach does not increase operative time and complication rates in comparison to the multi-port robotic-assisted system.

11 August 2025 in Minimally Invasive Therapy & Allied Technologies
Verified
Journal Article
Open access
Riccardo VizzaRiccardo Vizza
Riccardo Vizza
GCGiacomo Corrado
Giacomo Corrado
EMEmanuela Mancini
Emanuela Mancini
EBErmelinda Baiocco
Ermelinda Baiocco
MRMario Russo
Mario Russo
EVEnrico Vizza
Enrico Vizza
The purpose of this study was to evaluate the feasibility, safety, and efficacy of robotic single-port hysterectomy (R-SPH) with the da Vinci SP in low-risk endometrial cancer. Patients with clinically confirmed endometrioid endometrial cancer, FIGO stages IA-IB, were enrolled for R-SPH. All surgical procedures were performed through a single 2.5 cm umbilical incision. An Intuitive Access Port of small size was placed into the incision, and pneumoperitoneum was established. Robotic instruments were inserted as described below through the Intuitive Access Port, which has four different channel ports: in the superior channel, a three-dimensional 8.5 mm optics; in channel 1, Cadiere Forceps; in channel 2, a Maryland Bipolar; and in channel 3, monopolar scissors. From June 24 to November 13, 2024, a total of 25 patients were included in the study. The median age was 61 years, and median BMI was 25.9 kg/m2. The median docking time, console time, and total operative time were 10, 65, and 115 min, respectively. The median blood loss was 67.0 mL, and the median hemoglobin drop was 1.2 g/dL. R-SPH seems safe and feasible in endometrial cancer. The true benefit of the technique should be sought in larger comparative studies. ClinicalTrials.gov Protocol Record: NCT06681831.

15 September 2025 in The International Journal of Medical Robotics and Computer Assisted Surgery
Verified
Journal Article
Open access
Riccardo VizzaRiccardo Vizza
Riccardo Vizza
GCGiacomo Corrado
Giacomo Corrado
VBValentina Bruno
Valentina Bruno
EBErmelinda Baiocco
Ermelinda Baiocco
PZPier Carlo Zorzato
Pier Carlo Zorzato
EVEnrico Vizza
Enrico Vizza
Objective: To compare surgical outcomes of robotic single‐port (RSPH) versus single‐site (RSSH) hysterectomy in early‐stage endometrial cancer. Methods: This is a retrospective case‐control study, comparing surgical outcomes of RSPH (Cases) and RSSH (Controls) in early‐stage endometrial cancer. Results: Twenty‐five women who underwent RSPH from June 2024 to November 2024 were matched with 50 historical RSSH controls treated at the same institution by the same surgical team between December 2011 and September 2014. Operation time was similar: 110 min in RSPH and 99 min in RSSH ( p = 0.76). Blood loss was 50 mL in RSPH and 60 mL in RSSH ( p = 0.14). Hospital stay was shorter in RSSH (3.5 days in RSPH and 3 days in RSSH, p = 0.001). Conclusions: Our study confirms the safety and feasibility of RSPH for endometrial cancer without major differences from the RSSH in terms of surgical outcomes.

1 April 2025 in Medicina
Verified
Journal Article
Open access
PDF file
PZPier Carlo Zorzato
Pier Carlo Zorzato
Riccardo VizzaRiccardo Vizza
Riccardo Vizza
Simone GarzonSimone Garzon
Simone Garzon
MBMariachiara Bosco
Mariachiara Bosco
AFAnna Festi
Anna Festi
SUStefano Uccella
Stefano Uccella
Background and Objectives: Vaginal cuff dehiscence (VCD) represents a rare but relevant complication that occurs following minimally invasive hysterectomy. With the rising frequency of this procedure, it is crucial to continuously evaluate VCD incidence, risk factors, and prevention strategies. This systematic review and meta-analysis aimed to update the evidence on VCD incidence and to assess the role of various surgical techniques and materials adopted for vaginal cuff closure. Materials and Methods: A systematic literature search was conducted in PubMed, Scopus, Web of Science, EMBASE, and the Cochrane Library for studies published up to January 2025. Eligible studies reported VCD rates after laparoscopic or robotic hysterectomy for benign conditions and compared different closure techniques. The primary outcome was the incidence of VCD across closure methods, while secondary outcomes included potential risk factors. A random-effects model estimated pooled VCD rates with 95% confidence intervals (CI), and heterogeneity was assessed using I2 tests. Results: Twenty-six studies involving 10,039 patients were analyzed. The overall pooled incidence of VCD was 0.7% (95% CI: 0.4–1.1%), with higher estimates in randomized controlled trials (RCTs) (1.4%) compared to non-RCTs (0.5%). Robotic-assisted hysterectomy had a pooled VCD rate of 1.7%, compared to laparoscopic hysterectomy at 0.7%. Although not statistically significant, transvaginal closure showed a higher VCD risk than laparoscopic closure (2.3% vs. 1.16%; OR 0.97, 95% CI, 0.33–2.82; OR 2.53 (95% CI, 1.10–5.82) when considering only RCTs), and barbed sutures showed a lower VCD incidence (0.35%) than conventional sutures (1.52%) (OR 0.37, 95% CI, 0.13–1.02). Smoking was identified as a significant risk factor for VCD, while the impact of early postoperative sexual activity remains inconclusive. Conclusions: Laparoscopic closure rather than transvaginal cuff closure and barbed sutures were neither significantly associated with reducing VCD risk. Emphasizing smoking cessation preoperatively is essential for VCD prevention. Future studies should investigate the effects of postoperative sexual activity and refine surgical techniques to minimize VCD risk and improve outcomes.